Immigrant detainees across at least 33 states allege in court documents that the government is failing to provide them with ...
Discusses Preliminary Phase I Data for SIM0505 in Platinum-Resistant Ovarian Cancer and Uterine Serous Carcinoma June 2, 2026 8:00 ...
As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally ...
Oculis will not pursue FDA approval for OCS-01, an eye drop for diabetic macular edema, after it failed to meet the primary ...
Aglatimagene is an investigational therapy that uses a modified virus to deliver a cancer-fighting gene into tumor cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results